Inventor · disambiguated record
Eric L. Stangeland
Also filed as: STANGELAND ERIC · STANGELAND ERIC L · STANGELAND ERIC LARS
66 granted patents·7 pending applications·744 citations·filing 2004–2023
99Inventor score
Files withSTANGELAND ERIC L16THERAVANCE INC16THERAVANCE RESPIRATORY CO LLC9THERAVANCE BIOPHARMA R&D IP LLC7VALO HEALTH INC5
Top patents by PatentIndex Score
73 records- 0197US10722504B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Jul 28, 2020·5 cites·18 claims
- 0297US10206913B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 19, 2019·11 cites·2 claims
- 0397US10034870B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jul 31, 2018·12 cites·10 claims
- 0497US9675599B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2015·Granted Jun 13, 2017·17 cites·4 claims
- 0597US8247433B2Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsSTANGELAND ERIC L·Filed 2009·Granted Aug 21, 2012·23 cites·9 claims
- 0697US7262205B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Aug 28, 2007·50 cites·21 claims
- 0796US8604058B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2012·Granted Dec 10, 2013·20 cites·24 claims
- 0896US8304432B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2009·Granted Nov 6, 2012·25 cites·26 claims
- 0996US7514558B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 7, 2009·32 cites·18 claims
- 1096US7479562B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jan 20, 2009·39 cites·24 claims
- 1196US7141671B2Biphenyl derivativesTHERAVANCE INC·Filed 2004·Granted Nov 28, 2006·145 cites·42 claims
- 1295US11548886B2Monocyclic compounds useful as GPR120 modulatorsVALO HEALTH INC·Filed 2020·Granted Jan 10, 2023·4 cites·10 claims
- 1395US10946007B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Mar 16, 2021·2 cites·4 claims
- 1495US10441579B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Oct 15, 2019·7 cites·9 claims
- 1595US9162982B24-[2-(2-fluorophenoxy methyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2013·Granted Oct 20, 2015·15 cites·20 claims
- 1695US7888386B23-(phenoxyphenylmethyl)pyrrolidine compoundsTHERAVANCE INC·Filed 2009·Granted Feb 15, 2011·30 cites·54 claims
- 1795US7642355B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jan 5, 2010·32 cites·15 claims
- 1895US7629336B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Dec 8, 2009·29 cites·12 claims
- 1994US7879879B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Feb 1, 2011·19 cites·7 claims
- 2094US7683173B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Mar 23, 2010·23 cites·21 claims
- 2192US7851631B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Dec 14, 2010·15 cites·17 claims
- 2292US7728144B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jun 1, 2010·20 cites·17 claims
- 2391US9682957B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Jun 20, 2017·5 cites·2 claims
- 2491US9572802B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Feb 21, 2017·5 cites·30 claims
- 2591US9000173B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2014·Granted Apr 7, 2015·7 cites·5 claims
- 2691US8816088B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE INC·Filed 2013·Granted Aug 26, 2014·7 cites·1 claims
- 2791US8138345B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM·Filed 2010·Granted Mar 20, 2012·13 cites·3 claims
- 2890US9975875B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted May 22, 2018·4 cites·3 claims
- 2990US8551978B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2012·Granted Oct 8, 2013·7 cites·6 claims
- 3090US7868175B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2009·Granted Jan 11, 2011·11 cites·13 claims
- 3189US9771350B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted Sep 26, 2017·4 cites·2 claims
- 3289US8329911B2Biphenyl compounds useful as muscarinic receptor antagonistsMU YONGQI·Filed 2009·Granted Dec 11, 2012·12 cites·17 claims
- 3388US8242164B23-(phenoxyphenylmethyl)pyrrolidine compoundsSTANGELAND ERIC L·Filed 2011·Granted Aug 14, 2012·9 cites·9 claims
- 3487US10800773B2Monocyclic compounds useful as GPR120 modulatorsINTEGRAL HEALTH INC·Filed 2017·Granted Oct 13, 2020·5 cites·20 claims
- 3587US8802857B2Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsSTANGELAND ERIC L·Filed 2012·Granted Aug 12, 2014·4 cites·4 claims
- 3687US8067439B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2010·Granted Nov 29, 2011·8 cites·17 claims
- 3786US9012460B21-(2-phenoxymethylphenyl)piperazine compoundsSTANGELAND ERIC L·Filed 2014·Granted Apr 21, 2015·7 cites·3 claims
- 3886US8530663B21-(2-phenoxymethylheteroaryl)piperidine and piperazine compoundsSTANGELAND ERIC L·Filed 2011·Granted Sep 10, 2013·8 cites·13 claims
- 3986US8501776B2Biphenyl compounds useful as muscarinic receptor antagonistsJI YUHUA·Filed 2010·Granted Aug 6, 2013·7 cites·13 claims
- 4085US8778949B21-(2-phenoxymethylphenyl)piperazine compoundsSTANGELAND ERIC L·Filed 2011·Granted Jul 15, 2014·7 cites·8 claims
- 4185US8618131B2Biphenyl derivativesMAMMEN MATHAI·Filed 2012·Granted Dec 31, 2013·3 cites·2 claims
- 4284US10865201B2Bicyclic compounds useful as GPR120 modulatorsVALO HEALTH INC·Filed 2017·Granted Dec 15, 2020·4 cites·20 claims
- 4384US9187423B2Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsSTANGELAND ERIC L·Filed 2014·Granted Nov 17, 2015·2 cites·2 claims
- 4484US8921372B2Inhibitors of hepatitis C virusMCKINNELL ROBERT MURRAY·Filed 2011·Granted Dec 30, 2014·8 cites·18 claims
- 4584US8242135B2Biphenyl derivativesMAMMEN MATHAI·Filed 2011·Granted Aug 14, 2012·3 cites·2 claims
- 4681US10138220B1Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Nov 27, 2018·1 cites·26 claims
- 4780US11723900B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 15, 2023·0 cites·5 claims
- 4879US8471040B2Serotonin reuptake inhibitorsSTANGELAND ERIC L·Filed 2011·Granted Jun 25, 2013·3 cites·21 claims
- 4979US8399488B2Biphenyl compounds useful as muscarinic receptor antagonistsJI YUHUA·Filed 2012·Granted Mar 19, 2013·3 cites·14 claims
- 5079US8013152B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2010·Granted Sep 6, 2011·3 cites·19 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eric L. Stangeland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →